![Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763422001634-gr3.jpg)
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect
![Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice | ACS Chemical Neuroscience Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.6b00131/asset/images/medium/cn-2016-001313_0008.gif)
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice | ACS Chemical Neuroscience
![Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining | Neuropsychopharmacology Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2013.307/MediaObjects/41386_2014_Article_BFnpp2013307_Fig1_HTML.jpg)
Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining | Neuropsychopharmacology
![Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763422001634-gr2.jpg)
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect
![Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763422001634-gr1.jpg)
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts - ScienceDirect
![mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats | Neuropsychopharmacology mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpp.2008.140/MediaObjects/41386_2009_Article_BFnpp2008140_Fig1_HTML.jpg)
mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats | Neuropsychopharmacology
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
![Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.5b00010/asset/images/large/cn-2015-000103_0009.jpeg)